Comparison of two ASC-derived therapeutics in an in vitro OA model: secretome versus extracellular vesicles

[1]  E. Andreu,et al.  Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study , 2020, EClinicalMedicine.

[2]  G. Banfi,et al.  Management of Osteoarthritis During the COVID‐19 Pandemic , 2020, Clinical pharmacology and therapeutics.

[3]  P. De Luca,et al.  Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease , 2020, Stem Cell Research & Therapy.

[4]  P. Gentile,et al.  Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease , 2020, Aging and disease.

[5]  Š. Kubínová,et al.  A Comparative Analysis of Multipotent Mesenchymal Stromal Cells derived from Different Sources, with a Focus on Neuroregenerative Potential , 2020, Scientific Reports.

[6]  C. Richardson,et al.  A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum , 2020, Scientific Reports.

[7]  M. Moretti,et al.  Secretome and Extracellular Vesicles as New Biological Therapies for Knee Osteoarthritis: A Systematic Review , 2019, Journal of clinical medicine.

[8]  M. Coleman,et al.  Conditioned Medium of Mesenchymal Stromal Cells: A New Class of Therapeutics , 2019, Biochemistry (Moscow).

[9]  S. Casati,et al.  Adipose-derived stromal cell secretome reduces TNFα-induced hypertrophy and catabolic markers in primary human articular chondrocytes. , 2019, Stem cell research.

[10]  D. Chu,et al.  Adipose Tissue Stem Cells for Therapy: An Update on the Progress of Isolation, Culture, Storage, and Clinical Application , 2019, Journal of clinical medicine.

[11]  Pietro Gentile,et al.  Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development , 2019, Cells.

[12]  James E. Tomkins,et al.  Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins , 2019, Stem cell research & therapy.

[13]  P. Gentile,et al.  Engineered Fat Graft Enhanced with Adipose-Derived Stromal Vascular Fraction Cells for Regenerative Medicine: Clinical, Histological and Instrumental Evaluation in Breast Reconstruction , 2019, Journal of clinical medicine.

[14]  P. De Luca,et al.  Interaction with hyaluronan matrix and miRNA cargo as contributors for in vitro potential of mesenchymal stem cell-derived extracellular vesicles in a model of human osteoarthritic synoviocytes , 2019, Stem cell research & therapy.

[15]  R. Frank,et al.  The Role of Orthobiologics in the Management of Osteoarthritis and Focal Cartilage Defects. , 2019, Orthopedics.

[16]  F. Barry,et al.  Mesenchymal Stem Cell Therapy for Osteoarthritis: The Critical Role of the Cell Secretome , 2019, Front. Bioeng. Biotechnol..

[17]  G. Camussi,et al.  Raman spectroscopy as a quick tool to assess purity of extracellular vesicle preparations and predict their functionality , 2019, Journal of extracellular vesicles.

[18]  R. Frank,et al.  Ortho-Biologics for Osteoarthritis. , 2019, Clinics in sports medicine.

[19]  G. Farronato,et al.  Nitrogen Containing Bisphosphonates Impair the Release of Bone Homeostasis Mediators and Matrix Production by Human Primary Pre-Osteoblasts , 2019, International journal of medical sciences.

[20]  D. Yellon,et al.  Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential , 2018, Journal of extracellular vesicles.

[21]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[22]  T. Ochiya,et al.  Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases , 2018, Journal of clinical medicine.

[23]  C. Simmons,et al.  Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering , 2018, Stem cells international.

[24]  G. Banfi,et al.  Differential Proteomic Analysis Predicts Appropriate Applications for the Secretome of Adipose-Derived Mesenchymal Stem/Stromal Cells and Dermal Fibroblasts , 2018, Stem Cells International.

[25]  R. Rahbarghazi,et al.  Diabetic sera disrupted the normal exosome signaling pathway in human mesenchymal stem cells in vitro , 2018, Cell and Tissue Research.

[26]  M. Goldring,et al.  Phenotypic instability of chondrocytes in osteoarthritis: on a path to hypertrophy , 2018, Annals of the New York Academy of Sciences.

[27]  S. Kletukhina,et al.  Evaluation of Cytochalasin B-Induced Membrane Vesicles Fusion Specificity with Target Cells , 2018, BioMed research international.

[28]  Graça Raposo,et al.  Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.

[29]  D. Saris,et al.  Mesenchymal Stromal/stem Cell-derived Extracellular Vesicles Promote Human Cartilage Regeneration In Vitro , 2018, Theranostics.

[30]  E. Parati,et al.  Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles. , 2017, Anti-cancer agents in medicinal chemistry.

[31]  Hyoseung Shin,et al.  Up-to-date Clinical Trials of Hair Regeneration Using Conditioned Media of Adipose-Derived Stem Cells in Male and Female Pattern Hair Loss. , 2017, Current stem cell research & therapy.

[32]  H. Suga,et al.  Hair Regeneration Therapy: Application of Adipose-Derived Stem Cells , 2017, Current stem cell research & therapy.

[33]  A. Awidi,et al.  Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy , 2017, CNS neuroscience & therapeutics.

[34]  M. Masserini,et al.  Raman spectroscopy uncovers biochemical tissue-related features of extracellular vesicles from mesenchymal stromal cells , 2017, Scientific Reports.

[35]  L. Rodella,et al.  Therapeutic effect of human adipose-derived stem cells and their secretome in experimental diabetic pain , 2017, Scientific Reports.

[36]  E. Pinatel,et al.  Extracellular vesicle-packaged miRNA release after short-term exposure to particulate matter is associated with increased coagulation , 2017, Particle and Fibre Toxicology.

[37]  H. Hibi,et al.  Clinical Study of Bone Regeneration by Conditioned Medium From Mesenchymal Stem Cells After Maxillary Sinus Floor Elevation , 2017, Implant dentistry.

[38]  Q. Wang,et al.  Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum , 2017, International journal of molecular medicine.

[39]  L. Troeberg,et al.  ADAMTS and ADAM metalloproteinases in osteoarthritis – looking beyond the ‘usual suspects’ , 2017, Osteoarthritis and cartilage.

[40]  I. Miinalainen,et al.  Confounding factors of ultrafiltration and protein analysis in extracellular vesicle research , 2017, Scientific Reports.

[41]  A. Caplan.  Mesenchymal Stem Cells: Time to Change the Name! , 2017, Stem cells translational medicine.

[42]  P. Horn,et al.  Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury , 2017, Brain, Behavior, and Immunity.

[43]  E. Arrigoni,et al.  17β-estradiol differently affects osteogenic differentiation of mesenchymal stem/stromal cells from adipose tissue and bone marrow. , 2016, Differentiation; research in biological diversity.

[44]  S. Goldring,et al.  Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage–bone crosstalk , 2016, Nature Reviews Rheumatology.

[45]  C. Naus,et al.  The C-terminal domain of connexin43 modulates cartilage structure via chondrocyte phenotypic changes , 2016, Oncotarget.

[46]  F Guillemin,et al.  Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies. , 2016, Osteoarthritis and cartilage.

[47]  Wael Nassar,et al.  Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases , 2016, Biomaterials Research.

[48]  U. Galderisi,et al.  Clinical Trials with Mesenchymal Stem Cells: An Update , 2016, Cell transplantation.

[49]  A. Carr,et al.  Dickkopf-3 is upregulated in osteoarthritis and has a chondroprotective role , 2016, Osteoarthritis and cartilage.

[50]  F. Angiero,et al.  Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel , 2016, Expert opinion on drug delivery.

[51]  C. Manferdini,et al.  Lack of anti-inflammatory and anti-catabolic effects on basal inflamed osteoarthritic chondrocytes or synoviocytes by adipose stem cell-conditioned medium. , 2015, Osteoarthritis and cartilage.

[52]  N. Morioka,et al.  Proinflammatory cytokines downregulate connexin 43-gap junctions via the ubiquitin-proteasome system in rat spinal astrocytes. , 2015, Biochemical and biophysical research communications.

[53]  M. De Bock,et al.  Intracellular Cleavage of the Cx43 C-Terminal Domain by Matrix-Metalloproteases: A Novel Contributor to Inflammation? , 2015, Mediators of Inflammation.

[54]  H. Hibi,et al.  Conditioned Medium From Mesenchymal Stem Cells Enhances Early Bone Regeneration After Maxillary Sinus Floor Elevation in Rabbits , 2015, Implant dentistry.

[55]  Q. Zheng,et al.  Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation , 2014, Cell Death and Disease.

[56]  Di Chen,et al.  TGF-β signaling and the development of osteoarthritis , 2014, Bone Research.

[57]  M. Epple,et al.  MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease , 2014, Leukemia.

[58]  S Lohmander,et al.  OARSI guidelines for the non-surgical management of knee osteoarthritis. , 2014, Osteoarthritis and cartilage.

[59]  M. Raimondi,et al.  Characterization of articular chondrocytes isolated from 211 osteoarthritic patients , 2014, Cell and Tissue Banking.

[60]  Andrew F. Hill,et al.  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.

[61]  A. Addis,et al.  Porcine adipose-derived stem cells from buccal fat pad and subcutaneous adipose tissue for future preclinical studies in oral surgery , 2013, Stem Cell Research & Therapy.

[62]  Yang Xu,et al.  The Effect of Conditioned Media of Adipose-Derived Stem Cells on Wound Healing after Ablative Fractional Carbon Dioxide Laser Resurfacing , 2013, BioMed research international.

[63]  C. Manferdini,et al.  Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis. , 2013, Stem cell research.

[64]  C. Manferdini,et al.  Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. , 2013, Arthritis and rheumatism.

[65]  A. Mikos,et al.  Repair of osteochondral defects with rehydrated freeze-dried oligo[poly(ethylene glycol) fumarate] hydrogels seeded with bone marrow mesenchymal stem cells in a porcine model. , 2013, Tissue engineering. Part A.

[66]  H. Im,et al.  MMP13 is a critical target gene during the progression of osteoarthritis , 2013, Arthritis Research & Therapy.

[67]  Changqing Zhang,et al.  Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. , 2012, Biomaterials.

[68]  M. Coolsen,et al.  Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures. , 2012, Osteoarthritis and cartilage.

[69]  Y. Hu,et al.  Collagen fibril stiffening in osteoarthritic cartilage of human beings revealed by atomic force microscopy. , 2012, Osteoarthritis and cartilage.

[70]  T. Nishida,et al.  Role of the JNK Signaling PathWay in Downregulation of Connexin43 by TNF-α in Human Corneal Fibroblasts , 2012, Current eye research.

[71]  P. D. Kraan,et al.  Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? , 2012 .

[72]  Stefan Rose-John,et al.  ADAM17: a molecular switch to control inflammation and tissue regeneration. , 2011, Trends in immunology.

[73]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[74]  P. Kongtawelert,et al.  Versican Facilitates Chondrocyte Differentiation and Regulates Joint Morphogenesis* , 2010, The Journal of Biological Chemistry.

[75]  M. Karsdal,et al.  Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis. , 2010, The American journal of pathology.

[76]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[77]  A. V. van Wijnen,et al.  Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. , 2009, Arthritis and rheumatism.

[78]  S. Abramson,et al.  Prostaglandin E2 Exerts Catabolic Effects in Osteoarthritis Cartilage: Evidence for Signaling via the EP4 Receptor1 , 2008, The Journal of Immunology.

[79]  Ping-Heng Tan,et al.  Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain , 2008, Nature Medicine.

[80]  J. Hui,et al.  Injectable Mesenchymal Stem Cell Therapy for Large Cartilage Defects—A Porcine Model , 2007, Stem cells.

[81]  S. Keleş,et al.  The bone morphogenetic protein 1/Tolloid-like metalloproteinases. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[82]  D. Zukor,et al.  Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy , 2007, Arthritis research & therapy.

[83]  Jialiang Hu,et al.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases , 2007, Nature Reviews Drug Discovery.

[84]  F. Canovas,et al.  Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes , 2007, Arthritis research & therapy.

[85]  S. Jimenez,et al.  NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis , 2006 .

[86]  E. Schwarz,et al.  PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. , 2004, Experimental cell research.

[87]  I. Martin,et al.  Enzymatic Digestion of Adult Human Articular Cartilage Yields a Small Fraction of the Total Available Cells , 2003, Connective tissue research.

[88]  L. Armstrong,et al.  Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis. , 2000, Osteoarthritis and cartilage.

[89]  D. Greenspan,et al.  Bone Morphogenetic Protein-1: The Type I Procollagen C-Proteinase , 1996, Science.

[90]  G. Rasperini,et al.  Impact of Dental Implant Surface Modifications on Adhesion and Proliferation of Primary Human Gingival Keratinocytes and Progenitor Cells. , 2018, The International journal of periodontics & restorative dentistry.

[91]  H. Donahue,et al.  Joint diseases: from connexins to gap junctions , 2017, Nature Reviews Rheumatology.

[92]  Jie Liu,et al.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders. , 2017, Progress in molecular biology and translational science.

[93]  D. Saris,et al.  Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes. , 2014, Osteoarthritis and cartilage.

[94]  F. Berenbaum,et al.  Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). , 2013, Osteoarthritis and cartilage.

[95]  W. B. van den Berg,et al.  Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? , 2012, Osteoarthritis and cartilage.

[96]  E. Arrigoni,et al.  Human adipose-derived stem cells isolated from young and elderly women: their differentiation potential and scaffold interaction during in vitro osteoblastic differentiation. , 2009, Cytotherapy.

[97]  S. Jimenez,et al.  NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. , 2006, Osteoarthritis and cartilage.

[98]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[99]  M. Goldring.  Human chondrocyte cultures as models of cartilage-specific gene regulation. , 1996, Methods in molecular medicine.